Viewing Study NCT02965157


Ignite Creation Date: 2025-12-24 @ 6:58 PM
Ignite Modification Date: 2026-01-04 @ 12:01 AM
Study NCT ID: NCT02965157
Status: UNKNOWN
Last Update Posted: 2016-11-16
First Post: 2016-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma
Sponsor: Beijing Biohealthcare Biotechnology Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module